Weiss Guenter, Lippert Hans, Meyer Frank
Intensive Care Unit, Department of General, Abdominal, Vascular Surgery University Hospital, Magdeburg, Germany.
Pol Przegl Chir. 2012 Apr;84(4):214-8. doi: 10.2478/v10035-012-0035-y.
Patients with non-occlusive mesenteric ischemia (NOMI) are still confronted with high mortality. The diagnostic is challenging and difficult because of the unspecific symptomatology. The aim of this systematic scientific report on an extraordinary and uncommon single clinical case and its successful course was to demonstrate the great potential of a partially novel non-surgical approach including its periinterventional management. A 73-year old female is precisely described, who developed an acute abdomen during the postoperative course after cardiosurgical intervention. Only explorative laparotomy clarified the correct diagnosis - NOMI. Despite general intensive care, patient developed multi-organ failure after this second intervention. Using consequently an image-guided minimally invasive radiological approach comprising the introduction of a catheter into the superior mesenteric artery (Seldinger's technique) and the continuous application of vasodilating medication such as alprostadil (prostaglandin) through this catheter enabled us to improve mesenteric perfusion effectively and to overcome multiorgan failure.In conclusion, specific risk factors may help to focus on the suspicion of NOMI. Diagnostic of choice is the arterial mesentericography, which allows specifically to exclude vascular occlusion including the consequence of a prompt surgical approach. Simultaneously, using the setting of the mesenteric angiography catheter can be placed for initiation of regional vasodilating treatment in case of NOMI. Only this approach may avoid fatal outcome.
非闭塞性肠系膜缺血(NOMI)患者仍然面临着高死亡率。由于症状不具特异性,其诊断具有挑战性且困难。这份关于一个特殊且罕见的临床病例及其成功治疗过程的系统性科学报告的目的是展示一种部分新颖的非手术方法的巨大潜力,包括其介入治疗期间的管理。文中精确描述了一名73岁女性,她在心脏外科手术后的病程中出现了急腹症。只有通过剖腹探查术才明确了正确诊断——NOMI。尽管进行了全面的重症监护,但在这次二次干预后患者仍出现了多器官功能衰竭。通过持续采用影像引导下的微创放射学方法,即将导管插入肠系膜上动脉(Seldinger技术),并通过该导管持续应用血管扩张药物如前列地尔(前列腺素),使我们能够有效改善肠系膜灌注并克服多器官功能衰竭。总之,特定的风险因素可能有助于关注对NOMI的怀疑。首选诊断方法是肠系膜动脉造影,它能够特别排除血管闭塞,包括及时采取手术方法的后果。同时,在进行肠系膜血管造影时,若诊断为NOMI,可放置导管以启动局部血管扩张治疗。只有这种方法才能避免致命后果。